Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESKAPE
NCT06853041Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- May 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esketamine in acute pain, sponsored by Centre Hospitalier Universitaire de Nice. Started May 2025; status: completed.
02
Drugs
esketamine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT06853041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06853041.